Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

5.4%

2 terminated out of 37 trials

Success Rate

92.0%

+5.5% vs benchmark

Late-Stage Pipeline

30%

11 trials in Phase 3/4

Results Transparency

39%

9 of 23 completed with results

Key Signals

9 with results92% success

Data Visualizations

Phase Distribution

31Total
Not Applicable (10)
Early P 1 (1)
P 1 (4)
P 2 (5)
P 3 (11)

Trial Status

Completed23
Unknown4
Not Yet Recruiting2
Terminated2
Recruiting2
Active Not Recruiting1

Trial Success Rate

92.0%

Benchmark: 86.5%

Based on 23 completed trials

Clinical Trials (37)

Showing 20 of 20 trials
NCT07699367Early Phase 1Not Yet RecruitingPrimary

Metformin and ACLR Muscle Recovery

NCT05698316Completed

A Collaborative Resource of Heidelberg Multimodal Imaging of Intermediate and Early Atrophic AMD Cases to Study Prediction of Disease Progression

NCT05869812Phase 2RecruitingPrimary

Influence of β-hydroxy β-methyl Butyrate (HMB)Supplementation on Post-operative Muscle Mass and Function in Female Athletes

NCT05156320Phase 3Completed

Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or Risdiplam

NCT07090694Phase 1Enrolling By Invitation

PRF vs. Graftless Sinus Lift With Implant Placement

NCT07002333Not Yet Recruiting

Investigation of Respiratory Muscle Sarcopenia in Adults Diagnosed With Diabetes

NCT05626855Phase 3Active Not Recruiting

Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab

NCT03921528Phase 2Completed

An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular Atrophy

NCT05810272Not ApplicableUnknown

Impact of Postprandial 'Exercise Snacks' on Protein and Glucose Metabolism Following a Period of Step Reduction in Older Adults

NCT02137824Not ApplicableRecruiting

A Modified Sinus Floor Elevation Technique - a Pilot Study on 12 Patients

NCT02781623CompletedPrimary

Quantifying Quadriceps Atrophy Following Tibial Plateau Fracture

NCT00931268Not ApplicableCompletedPrimary

Morphological and Functional Evaluation of Buttock Lipoatrophy Treatment With Macrolane

NCT04589572Not ApplicableSuspended

Extreme Lateral Interbody FusionFUSION (XLIF) Versus Posterior Lumbar Interbody Fusion (PLIF)

NCT02770365Phase 3CompletedPrimary

Comparative Safety and Efficacy of Two Treatments in the Treatment of Vulvar and Vaginal Atrophy

NCT04284748Not ApplicableCompleted

Effect of Blood Flow Restriction Training on Patient With Anterior Cruciate Ligament Reconstruction

NCT02868749Not ApplicableCompletedPrimary

Histology and Ultrasound Pilot Study of HA Gels Adipose Tissue

NCT03616197Not ApplicableCompleted

The Effect of Different Gingival Biotypes on Dimensional Stability of Free Gingival Graft

NCT01585558Phase 3CompletedPrimary

Long-Term Safety of 30 mg and 60 mg Oral Daily Dose of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women With Intact Uterus

NCT01586364Phase 3CompletedPrimary

Long-Term Safety of Ospemifene 60 mg Oral Daily Dose for the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women Without a Uterus

NCT00566982Phase 3CompletedPrimary

A Clinical Study to Evaluate the Safety of Ospemifene

Scroll to load more

Research Network

Activity Timeline